9-34645848-A-ATT

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1

The ENST00000605275.1(GALT):​n.209-810_209-809dup variant causes a intron, non coding transcript change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.065 ( 385 hom., cov: 0)

Consequence

GALT
ENST00000605275.1 intron, non_coding_transcript

Scores

Not classified

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.901
Variant links:
Genes affected
GALT (HGNC:4135): (galactose-1-phosphate uridylyltransferase) Galactose-1-phosphate uridyl transferase (GALT) catalyzes the second step of the Leloir pathway of galactose metabolism, namely the conversion of UDP-glucose + galactose-1-phosphate to glucose-1-phosphate + UDP-galactose. The absence of this enzyme results in classic galactosemia in humans and can be fatal in the newborn period if lactose is not removed from the diet. The pathophysiology of galactosemia has not been clearly defined. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

BP6
Variant 9-34645848-A-ATT is Benign according to our data. Variant chr9-34645848-A-ATT is described in ClinVar as [Benign]. Clinvar id is 1331397.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0788 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GALTENST00000605275.1 linkuse as main transcriptn.209-810_209-809dup intron_variant, non_coding_transcript_variant 3

Frequencies

GnomAD3 genomes
AF:
0.0648
AC:
8138
AN:
125558
Hom.:
383
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0812
Gnomad AMI
AF:
0.165
Gnomad AMR
AF:
0.0532
Gnomad ASJ
AF:
0.0481
Gnomad EAS
AF:
0.00825
Gnomad SAS
AF:
0.0678
Gnomad FIN
AF:
0.0609
Gnomad MID
AF:
0.0504
Gnomad NFE
AF:
0.0627
Gnomad OTH
AF:
0.0495
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0649
AC:
8147
AN:
125538
Hom.:
385
Cov.:
0
AF XY:
0.0641
AC XY:
3818
AN XY:
59522
show subpopulations
Gnomad4 AFR
AF:
0.0814
Gnomad4 AMR
AF:
0.0533
Gnomad4 ASJ
AF:
0.0481
Gnomad4 EAS
AF:
0.00828
Gnomad4 SAS
AF:
0.0676
Gnomad4 FIN
AF:
0.0609
Gnomad4 NFE
AF:
0.0627
Gnomad4 OTH
AF:
0.0498

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpDec 14, 2021Variant summary: GALT c.-838_-837dupTT is located in the untranscribed region upstream of the GALT gene region. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.063 in 19482 control chromosomes, predominantly at a frequency of 0.08 within the African or African-American subpopulation in the gnomAD database, including 23 homozygotes. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 28 fold of the estimated maximal expected allele frequency for a pathogenic variant in GALT causing Galactosemia phenotype (0.0029), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no occurrence of c.-838_-837dupTT in individuals affected with Galactosemia and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs549043849; hg19: chr9-34645845; API